These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 4727362)
61. Xanthine oxidase inhibitory activity of new pyrrole carboxamide derivatives: In vitro and in silico studies. Kıbrız İE; Saçmacı M; Yıldırım İ; Abbas Ali Noma S; Taşkın Tok T; Ateş B Arch Pharm (Weinheim); 2018 Oct; 351(10):e1800165. PubMed ID: 30168852 [TBL] [Abstract][Full Text] [Related]
62. Novel, highly potent adenosine deaminase inhibitors containing the pyrazolo[3,4-d]pyrimidine ring system. Synthesis, structure-activity relationships, and molecular modeling studies. Da Settimo F; Primofiore G; La Motta C; Taliani S; Simorini F; Marini AM; Mugnaini L; Lavecchia A; Novellino E; Tuscano D; Martini C J Med Chem; 2005 Aug; 48(16):5162-74. PubMed ID: 16078836 [TBL] [Abstract][Full Text] [Related]
63. The existence of nonfunctional active sites in milk xanthine oxidase: reaction with functional active site inhibitors. Massey V; Komai H; Palmer G; Elion GB Vitam Horm; 1970; 28():505-31. PubMed ID: 4335890 [No Abstract] [Full Text] [Related]
64. Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines. Rashad AE; Hegab MI; Abdel-Megeid RE; Fathalla N; Abdel-Megeid FM Eur J Med Chem; 2009 Aug; 44(8):3285-92. PubMed ID: 19285757 [TBL] [Abstract][Full Text] [Related]
65. Synthesis of 7-(2-dimethylaminovinyl) derivatives of pyrazolo[1,5-a] pyrimidines, as precursors of new tricyclic series. Binding studies of BDZ receptor. Bruni F; Costanzo A; Selleri S; Guerrini G; Giusti L; Martini C; Lucacchini A Farmaco; 1993 Feb; 48(2):309-19. PubMed ID: 8388217 [TBL] [Abstract][Full Text] [Related]
66. An ecofriendly synthesis and DNA binding interaction study of some pyrazolo [1,5-a]pyrimidines derivatives. Chobe SS; Dawane BS; Tumbi KM; Nandekar PP; Sangamwar AT Bioorg Med Chem Lett; 2012 Dec; 22(24):7566-72. PubMed ID: 23122866 [TBL] [Abstract][Full Text] [Related]
67. Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives. Khobragade CN; Bodade RG; Konda SG; Dawane BS; Manwar AV Eur J Med Chem; 2010 Apr; 45(4):1635-8. PubMed ID: 20096486 [TBL] [Abstract][Full Text] [Related]
68. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents. Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656 [TBL] [Abstract][Full Text] [Related]
69. Cancerostatica. I. synthesis of some pyrazolo[1,5-a]pyrimidine and pyrazolo [3,4-b] pyridine derivatives. Nantka-Namirski P; Kaczmarek L Pol J Pharmacol Pharm; 1978; 30(4):563-8. PubMed ID: 740557 [TBL] [Abstract][Full Text] [Related]
70. [Thieno(2',3':3,4)pyrazolo(1,5-a)pyrimidines and -triazines: synthesis of a novel ring system]. Briel D Pharmazie; 1995 Oct; 50(10):675-8. PubMed ID: 7501690 [TBL] [Abstract][Full Text] [Related]
71. RETRACTED: Design, synthesis, structure-activity relationship and kinase inhibitory activity of substituted 3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ones. Lamie PF Bioorg Med Chem Lett; 2016 Jul; 26(13):3093-3097. PubMed ID: 27189674 [TBL] [Abstract][Full Text] [Related]
72. Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell lines. Manetti F; Brullo C; Magnani M; Mosci F; Chelli B; Crespan E; Schenone S; Naldini A; Bruno O; Trincavelli ML; Maga G; Carraro F; Martini C; Bondavalli F; Botta M J Med Chem; 2008 Mar; 51(5):1252-9. PubMed ID: 18257513 [TBL] [Abstract][Full Text] [Related]
73. Synthesis of 1H-pyrazolo[4,3-d]pyrimidine-7(6H)-ones and pyrazolo-5-carboxamides and interaction with benzodiazepine and adenosine A1 receptors in rat cerebral cortex. Baraldi PG; Casolari A; Manfredini S; Periotto V; Zanirato V; Florio C; Traversa V; Bertelli GM; Borea PA Arzneimittelforschung; 1988 Sep; 38(9):1262-5. PubMed ID: 2852012 [TBL] [Abstract][Full Text] [Related]
74. Studies on the mode of oxidation of pyrazolo(3,4-d)pyrimidine by aldehyde oxidase and xanthine oxidase. Johns DG; Spector T; Robins RK Biochem Pharmacol; 1969 Oct; 18(10):2371-83. PubMed ID: 5403975 [No Abstract] [Full Text] [Related]
75. Oxidation of 7-aminothiadiazolo(3,4-d)pyrimidines and 7-aminofurazano(3,4-d)pyrimidines by xanthine oxidase and aldehyde oxidase. McCormack JJ; Taylor EC Biochem Pharmacol; 1975 Sep; 24(17):1636-9. PubMed ID: 172085 [No Abstract] [Full Text] [Related]
76. Some pyrazole and pyrazolo[3,4-d]pyrimidine derivatives: synthesis and anticancer evaluation. Shamroukh AH; Rashad AE; Abdel-Megeid RE; Ali HS; Ali MM Arch Pharm (Weinheim); 2014 Aug; 347(8):559-65. PubMed ID: 24801813 [TBL] [Abstract][Full Text] [Related]
77. Synthesis, isomerization, and antimicrobial evaluation of some pyrazolopyranotriazolopyrimidine derivatives. Shamroukh AH; Zaki ME; Morsy EM; Abdel-Motti FM; Abdel-Megeid FM Arch Pharm (Weinheim); 2007 Jul; 340(7):345-51. PubMed ID: 17610300 [TBL] [Abstract][Full Text] [Related]
78. Synthesis and in vitro cytotoxic activity of novel pyrazolo[3,4-d]pyrimidines and related pyrazole hydrazones toward breast adenocarcinoma MCF-7 cell line. Hassan GS; Kadry HH; Abou-Seri SM; Ali MM; Mahmoud AE Bioorg Med Chem; 2011 Nov; 19(22):6808-17. PubMed ID: 22000322 [TBL] [Abstract][Full Text] [Related]
79. Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists. Gillespie P; Goodnow RA; Saha G; Bose G; Moulik K; Zwingelstein C; Myers M; Conde-Knape K; Pietranico-Cole S; So SS Bioorg Med Chem Lett; 2014 Feb; 24(3):949-53. PubMed ID: 24412066 [TBL] [Abstract][Full Text] [Related]
80. Irreversible enzyme inhibitors. CXXVI. Hydrocarbon interaction with xanthine oxidase by phenyl substituents on purines and pyrazolo[3,4-d]pyrimidines. Baker BR; Wood WF; Kozma JA J Med Chem; 1968 Jul; 11(4):661-6. PubMed ID: 5671224 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]